Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-18-001713
Filing Date
2018-08-14
Accepted
2018-08-14 16:05:54
Documents
3
Period of Report
2018-08-14

Document Format Files

Seq Description Document Type Size
1 FORM 6-K correvio6k.htm 6-K 16998
2 NEWS RELEASE DATED AUGUST 14, 2018 ex991.htm EX-99.1 131178
3 GRAPHIC logo.jpg GRAPHIC 16396
  Complete submission text file 0001279569-18-001713.txt   172110
Mailing Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7
Business Address 6TH FLOOR 1441 CREEKSIDE DRIVE VANCOUVER A1 V6J 4S7 1-604-677-6905
Correvio Pharma Corp. (Filer) CIK: 0001036141 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-29338 | Film No.: 181017376
SIC: 2834 Pharmaceutical Preparations